Can 9q34.2 rs633862 polymorphism predict survival in epithelial ovarian cancer?

by Rong Jiang, Yuan Xu, Pan Wang, Xi Cheng, Tingyan Shi, Rongyu Zang
Published 2017-11-01

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer

by Tingyan Shi, Pan Wang, Wenbin Tang, Rong Jiang, Sheng Yin, Di Shi, Qing Wang, Qingyi Wei, Rongyu Zang
Published 2018-07-01

REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells.

by Li Yang, Tingyan Shi, Fei Liu, Chunxia Ren, Ziliang Wang, Yingyi Li, Xiaoyu Tu, Gong Yang, Xi Cheng
Published 2015-01-01